Biotinylated platinum(IV) complexes designed to target cancer cells

Three biotinylated platinum(IV) complexes (1-3) were designed and synthesized for cancer targeting therapy, which could bind with the over-expressed biotin-specific receptors on the cancer cell surface, and then release the cytotoxic platinum(II) species at the tumor site by glutathione or ascorbic acid under biologically relevant condition.181